JP2013520440A5 - - Google Patents

Download PDF

Info

Publication number
JP2013520440A5
JP2013520440A5 JP2012554079A JP2012554079A JP2013520440A5 JP 2013520440 A5 JP2013520440 A5 JP 2013520440A5 JP 2012554079 A JP2012554079 A JP 2012554079A JP 2012554079 A JP2012554079 A JP 2012554079A JP 2013520440 A5 JP2013520440 A5 JP 2013520440A5
Authority
JP
Japan
Prior art keywords
compound
formula
pharmaceutically acceptable
acceptable salt
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2012554079A
Other languages
English (en)
Japanese (ja)
Other versions
JP5901543B2 (ja
JP2013520440A (ja
Filing date
Publication date
Priority claimed from PL390493A external-priority patent/PL219569B1/pl
Application filed filed Critical
Publication of JP2013520440A publication Critical patent/JP2013520440A/ja
Publication of JP2013520440A5 publication Critical patent/JP2013520440A5/ja
Application granted granted Critical
Publication of JP5901543B2 publication Critical patent/JP5901543B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2012554079A 2010-02-19 2011-02-19 環式テトラペプチド及びその治療応用 Expired - Fee Related JP5901543B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
PLP.390493 2010-02-19
PL390493A PL219569B1 (pl) 2010-02-19 2010-02-19 Cykliczne tetrapeptydy i ich zastosowanie
PCT/US2011/025571 WO2011103524A2 (en) 2010-02-19 2011-02-19 Cyclic tetrapeptides and therapeutic applications thereof

Publications (3)

Publication Number Publication Date
JP2013520440A JP2013520440A (ja) 2013-06-06
JP2013520440A5 true JP2013520440A5 (cg-RX-API-DMAC7.html) 2014-04-10
JP5901543B2 JP5901543B2 (ja) 2016-04-13

Family

ID=44483608

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012554079A Expired - Fee Related JP5901543B2 (ja) 2010-02-19 2011-02-19 環式テトラペプチド及びその治療応用

Country Status (13)

Country Link
US (3) US20130224232A1 (cg-RX-API-DMAC7.html)
EP (1) EP2536732B1 (cg-RX-API-DMAC7.html)
JP (1) JP5901543B2 (cg-RX-API-DMAC7.html)
KR (1) KR101704665B1 (cg-RX-API-DMAC7.html)
CN (1) CN102858779B (cg-RX-API-DMAC7.html)
AU (1) AU2011217882B2 (cg-RX-API-DMAC7.html)
BR (1) BR112012020833A2 (cg-RX-API-DMAC7.html)
CA (1) CA2827694C (cg-RX-API-DMAC7.html)
ES (1) ES2611663T3 (cg-RX-API-DMAC7.html)
IL (2) IL221535A (cg-RX-API-DMAC7.html)
PL (1) PL219569B1 (cg-RX-API-DMAC7.html)
RU (1) RU2568436C2 (cg-RX-API-DMAC7.html)
WO (1) WO2011103524A2 (cg-RX-API-DMAC7.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL219569B1 (pl) 2010-02-19 2015-05-29 Peptaderm Spółka Z Ograniczoną Odpowiedzialnością Cykliczne tetrapeptydy i ich zastosowanie
WO2016179398A1 (en) 2015-05-05 2016-11-10 Washington University Isoform-selective lysine deacetylase inhibitors
US10154997B2 (en) 2015-08-04 2018-12-18 Washington University Treatment of parasitic diseases using KDAC inhibitor compounds
US11325944B2 (en) 2017-06-16 2022-05-10 University Of Florida Research Foundation, Incorporated Macrocyclic peptides and derivatives thereof with opioid activity

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3862925A (en) * 1973-07-05 1975-01-28 American Home Prod Preparation of somatotropin release inhibiting factor and intermediates therefor
US3842067A (en) 1973-07-27 1974-10-15 American Home Prod Synthesis of(des-asn5)-srif and intermediates
JPS5726506B2 (cg-RX-API-DMAC7.html) * 1974-03-08 1982-06-04
IT1077010B (it) * 1976-09-01 1985-04-27 Snam Progetti Processo per la preparazione di copolimeri dell isobutilene contenenti insaturazioni ed atomi di alogeno reattivi
US4105603A (en) 1977-03-28 1978-08-08 The Salk Institute For Biological Studies Peptides which effect release of hormones
JPH0334991A (ja) * 1989-06-30 1991-02-14 Shionogi & Co Ltd 環状テトラペプチドおよびその製造法
US5216124A (en) 1989-12-15 1993-06-01 G. D. Searle & Co. Substituted cyclic tetrapeptides
US5541287A (en) 1992-06-09 1996-07-30 Neorx Corporation Pretargeting methods and compounds
US6777217B1 (en) * 1996-03-26 2004-08-17 President And Fellows Of Harvard College Histone deacetylases, and uses related thereto
US6013763A (en) * 1996-06-04 2000-01-11 Genentech, Inc. Peptide variants of protein A
US6281331B1 (en) 1998-03-23 2001-08-28 Trimeris, Inc. Methods and compositions for peptide synthesis
EP1071442B9 (en) * 1998-03-23 2006-01-18 Trimeris Inc. Methods and compositions for peptide synthesis (t-20)
DE19816922A1 (de) 1998-04-16 1999-10-21 Wolfgang Beck Einfache Synthese von cyclischen Tetrapeptiden aus nichtaktivierten Peptidestern an Metallzentren
AUPP505798A0 (en) * 1998-08-04 1998-08-27 Fujisawa Pharmaceutical Co., Ltd. Novel compound fr225497 substance
CZ20011342A3 (cs) 1998-10-13 2001-09-12 Fujisawa Pharmaceutical Co., Ltd. Cyklické tetrapeptidy
GB9903087D0 (en) * 1999-02-12 1999-03-31 Glaxo Group Ltd Process
DE602004009710T2 (de) * 2003-12-31 2008-08-07 F. Hoffmann-La Roche Ag Verfahren zur peptidsynthese unter verwendung einer reduzierten menge an entschützungsmittel
WO2006049597A1 (en) 2004-10-27 2006-05-11 Avanir Pharmaceuticals Amino acid-derived compounds as modulators of the reverse cholesterol transport
CN101115495B (zh) * 2004-12-14 2011-06-22 生物如恩克斯株式会社 通过runx2乙酰化作用增强bmp的骨形成活性的方法
EP2061512B1 (en) 2006-08-23 2019-10-02 Yeda Research And Development Co. Ltd. Conjugates of rgd peptides and (bacterio)chlorophyll photosensitizers and their uses
CN102036684B (zh) 2008-02-27 2017-06-09 耶达研究及发展有限公司 用于光动力疗法和坏死肿瘤成像的rgd‑(细菌)叶绿素缀合物
WO2010006267A2 (en) * 2008-07-11 2010-01-14 University Of Kansas Cyclic tetrapeptides
GB0918579D0 (en) 2009-10-22 2009-12-09 Imp Innovations Ltd Gadd45beta targeting agents
PL219569B1 (pl) 2010-02-19 2015-05-29 Peptaderm Spółka Z Ograniczoną Odpowiedzialnością Cykliczne tetrapeptydy i ich zastosowanie

Similar Documents

Publication Publication Date Title
TWI694982B (zh) 3-側氧基-3-(芳基胺基)丙酸酯,其製備程序,及其於製備吡咯酮的應用
JP2016040271A5 (cg-RX-API-DMAC7.html)
JP2012515142A5 (cg-RX-API-DMAC7.html)
RU2016143333A (ru) Амидные производные и их фармацевтически приемлемые соли, способ их получения и медицинское применение
JP2017533968A5 (cg-RX-API-DMAC7.html)
JP2014509322A5 (cg-RX-API-DMAC7.html)
JP2010523522A5 (cg-RX-API-DMAC7.html)
JP2017509586A5 (cg-RX-API-DMAC7.html)
JP2009541327A5 (cg-RX-API-DMAC7.html)
JP2011506566A5 (cg-RX-API-DMAC7.html)
JP2010539166A5 (cg-RX-API-DMAC7.html)
JP2009538910A5 (cg-RX-API-DMAC7.html)
JP2015535847A5 (cg-RX-API-DMAC7.html)
JP2013536188A5 (cg-RX-API-DMAC7.html)
JP2011523952A5 (cg-RX-API-DMAC7.html)
JP2016513696A5 (cg-RX-API-DMAC7.html)
JP2009533323A5 (cg-RX-API-DMAC7.html)
RU2010113358A (ru) Гуанидинсодержащие соединения, применимые в качестве антагонистов мускариновых рецепторов
JP2013520440A5 (cg-RX-API-DMAC7.html)
AU2014364410A1 (en) Process methods for phosphatidylinositol 3-kinase inhibitors
JP2009539943A5 (cg-RX-API-DMAC7.html)
JP2015500842A5 (cg-RX-API-DMAC7.html)
JP2017508733A5 (cg-RX-API-DMAC7.html)
JP2016540803A5 (cg-RX-API-DMAC7.html)
JP2013515037A5 (cg-RX-API-DMAC7.html)